Luz Alcantar-Vallin, Jose J. Zaragoza, Bladimir Díaz-Villavicencio, Karla Hernandez-Morales, Jahir R. Camacho-Guerrero, Miguel A. Perez-Venegas, Edgar J. Carmona-Morales, Alexa N. Oseguera-Gonzalez, Cesar Murguia-Soto, Gael Chávez-Alonso, José M. Arredondo-Dubois, Carlos E. Orozco-Chan, Juan A. Gómez-Fregoso, Francisco G. Rodríguez-García, Guillermo Navarro-Blackaller, Ramón Medina-González, Alejandro Martínez Gallardo-González, Gabriela J. Abundis-Mora, Olynka Vega-Vega, Guillermo García-García, Jonathan S. Chávez-Iñiguez
This research output has an Altmetric Attention Score of 62. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2024.
All research outputs
#736,903
of 26,512,053 outputs
Outputs from Frontiers in Pharmacology
#279
of 20,641 outputs
Outputs of similar age
#10,935
of 323,597 outputs
Outputs of similar age from Frontiers in Pharmacology
#7
of 318 outputs
Altmetric has tracked 26,512,053 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,641 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 323,597 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 318 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.
